| # | Drug | Count |
|---|---|---|
| 0 | ATEZOLIZUMAB | 26 |
| 1 | ADALIMUMAB | 7 |
| 2 | OMEPRAZOLE | 7 |
| 3 | OMEPRAZOLE MAGNESIUM | 7 |
| 4 | ACETAMINOPHEN | 6 |
| 5 | IBUPROFEN | 6 |
| 6 | METHYLPREDNISOLONE | 6 |
| 7 | ADALIMUMAB-AATY | 5 |
| 8 | ADALIMUMAB-ADAZ | 5 |
| 9 | ADALIMUMAB-FKJP | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM GLYCEROPHOSPHATE | 1 | 0.0027 |
| 1 | CROTAMITON | 1 | 0.0016 |
| 2 | SODIUM HYALURONATE | 1 | 0.0012 |
| 3 | ATEZOLIZUMAB | 26 | 0.0007 |
| 4 | FLURBIPROFEN | 1 | 0.0007 |
| 5 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 6 | TESTOSTERONE ENANTHATE | 1 | 0.0006 |
| 7 | PEGCETACOPLAN | 1 | 0.0005 |
| 8 | IMIQUIMOD | 1 | 0.0004 |
| 9 | LOMUSTINE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 30 |
| 1 | Corticosteroid [EPC] | 21 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 3 | Proton Pump Inhibitor [EPC] | 9 |
| 4 | Benzodiazepine [EPC] | 6 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| 6 | Aminosalicylate [EPC] | 5 |
| 7 | Opioid Agonist [EPC] | 5 |
| 8 | Osmotic Laxative [EPC] | 5 |
| 9 | Expectorant [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 30 | 0.0003 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 2 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 3 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 4 | Aminosalicylate [EPC] | 5 | 0.0000 |
| 5 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Glycopeptide Antibacterial [EPC] | 3 | 0.0000 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |